INSP R&D to Revenue
Inspire Medical Systems, Inc. Common Stock · R&D to Revenue
INSP R&D to Revenue
Latest reported11.31%period ending
INSP FY R&D/Revenue (88.35% → 11.31%)
Latest values, visible window
High-resolution chart · PNG
INSP r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.3122% | |
| 14.2162% | |
| 18.6518% | |
| 16.8307% | |
| 16.003% | |
| 22.6138% | |
| 15.6478% | |
| 14.6028% | |
| 21.6824% | |
| 43.1667% | |
| 88.355% |